Bio & Pharma
Lunit, Radiobotics team up to enter EMEA markets
The company partnered with the Denmark-based firm for distributing its chest X-ray image analysis solution Insight CXR
By May 02, 2024 (Gmt+09:00)
1
Min read
Most Read
LG Chem to sell water filter business to Glenwood PE for $692 million


Kyobo Life poised to buy Japan’s SBI Group-owned savings bank


KT&G eyes overseas M&A after rejecting activist fund's offer


StockX in merger talks with Naver’s online reseller Kream


Mirae Asset to be named Korea Post’s core real estate fund operator



South Korean medical AI company Lunit announced on Thursday that it partnered with the Danish musculoskeletal AI diagnostics company Radiobotics ApS to enter the Europe, Middle East, and Africa (EMEA) markets.
Under the agreement, the company will distribute Radiobotics' fracture and trauma detection solution RBfracture alongside its chest X-ray image analysis solution Lunit Insight CXR in the specified region.
Radiobotics will co-distribute Lunit Insight CXR when selling its products.
Lunit anticipates that patients in the EMEA region will benefit from the convenience of receiving comprehensive screenings for conditions ranging from lung diseases to fractures and trauma through X-ray imaging alone.
Write to Yena Kim at yena@hankyung.com
More to Read
-
Artificial intelligenceLunit gets court approval for Volpara acquisition in New Zealand
Mar 14, 2024 (Gmt+09:00)
1 Min read -
Artificial intelligenceLunit to supply AI image analysis solutions to Samsung Electronics
Jan 16, 2024 (Gmt+09:00)
1 Min read -
Bio & PharmaLunit acquires NZ-based AI diagnostics firm Volpara
Dec 14, 2023 (Gmt+09:00)
1 Min read -
Bio & PharmaLunit selected as contractor for building medical AI platform in Singapore
Dec 01, 2023 (Gmt+09:00)
1 Min read -
Artificial intelligenceLunit gets FDA approval for AI cancer diagnosis solution
Nov 14, 2023 (Gmt+09:00)
1 Min read
Comment 0
LOG IN